BioLife Solutions (BLFS) Balance Sheet: Assets & Liabilities

BioLife Solutions (BLFS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), BioLife Solutions reported total assets of $405.88M and total liabilities of $34.00M. Shareholders' equity was $371.89M, up 6.6% from $348.91M a year earlier. Total debt stood at $15.65M against $88.93M in cash and short-term investments, a net cash position of $73.27M. That puts debt-to-equity at 0.04, compared with 0.09 a year earlier.

BioLife Solutions Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for BioLife Solutions, Inc. (BLFS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	33.04	95.39	27.90	19.44	69.86	90.46	6.45	30.66	6.66
Short-Term Investments	55.89	9.20	16.29	43.26	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	88.93	104.58	44.18	62.70	69.86	90.46	6.45	30.66	6.66
Accounts Receivable	7.95	9.17	7.90	33.94	23.22	8.01	5.35	3.05	1.02
Inventory	30.16	29.01	27.16	34.90	28.35	11.60	11.12	3.51	1.85
Other Current Assets	9.53	6.00	4.67	6.91	4.67	4.65	1.26	0.35	0.40
Total Current Assets	136.56	148.76	120.60	138.45	126.09	114.71	24.18	37.56	9.93
Non-Current Assets
Property, Plant & Equipment (Net)	22.18	16.76	12.57	39.20	46.61	19.81	6.61	1.32	1.11
Long-Term Investments	31.25	5.62	5.07	6.40	4.37	5.87	2.50	6.55	1.07
Goodwill	208.59	212.30	212.30	224.74	224.74	58.45	33.64	0.00	0.00
Intangible Assets	4.26	9.56	12.00	32.09	152.15	31.05	21.98	0.00	0.00
Other Non-Current Assets	3.05	6.48	49.63	9.35	0.33	4.71	3.92	0.04	0.04
Total Non-Current Assets	269.32	250.73	292.11	311.78	428.20	120.12	68.83	7.90	2.21
Total Assets	405.88	399.49	412.71	450.23	554.29	234.83	93.01	45.47	12.14
Current Liabilities
Accounts Payable	1.49	3.57	2.27	15.37	14.95	3.67	3.12	0.72	0.69
Short-Term Debt	5.00	12.45	6.29	4.83	0.86	1.73	0.82	0.00	0.00
Current Portion of Long-Term Debt	5.00	10.94	6.29	1.81	0.86	0.61	-	-	-
Accrued Liabilities	5.85	7.19	6.62	9.78	6.87	3.37	-	-	-
Deferred Revenue	0.20	0.10	0.04	0.55	0.81	0.93	0.32	0.13	0.13
Other Current Liabilities	2.28	12.35	18.82	18.71	17.12	9.13	3.41	1.09	0.69
Total Current Liabilities	22.98	32.73	42.18	44.58	42.70	15.57	7.67	1.94	1.51
Non-Current Liabilities
Long-Term Debt	10.66	17.72	17.56	38.88	6.35	9.42	0.55	0.00	0.00
Deferred Tax Liabilities	0.19	0.12	0.11	0.25	5.49	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.17	0.08	6.50	2.33	10.43	4.52	41.14	28.90	0.54
Total Non-Current Liabilities	11.02	17.84	32.87	41.46	33.54	14.01	41.69	28.90	0.54
Total Liabilities	34.00	50.58	75.05	86.04	76.24	29.58	49.36	30.84	2.05
Stockholders' Equity
Common Stock	0.05	0.05	0.05	0.04	0.04	0.03	0.02	0.02	0.01
Retained Earnings	-339.70	-335.10	-314.92	-246.92	-107.11	-97.39	-100.05	-98.40	-73.96
Accumulated Other Comprehensive Income	0.13	0.02	-0.35	-0.68	-0.28	0.00	0.00	-2.33	-2.01
Additional Paid-in Capital	711.40	683.94	652.88	611.74	585.40	302.60	143.49	113.01	84.04
Shares Outstanding	48.20	46.91	45.17	42.83	41.82	-	-	-	-
Total Stockholders' Equity	371.89	348.91	337.66	364.19	478.05	205.25	83.03	14.63	10.09
Total Liabilities & Equity	405.88	399.49	412.71	450.23	554.29	234.83	93.01	45.47	12.14

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioLife Solutions Balance Sheet

How much debt does BioLife Solutions have?

BioLife Solutions had total debt of $15.65M as of Dec 31, 2025, against $88.93M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was $30.17M a year earlier.

What are BioLife Solutions's total assets?

BioLife Solutions reported total assets of $405.88M as of Dec 31, 2025, up 1.6% from $399.49M a year earlier. Total liabilities were $34.00M.

What is BioLife Solutions's shareholders' equity?

BioLife Solutions's shareholders' equity was $371.89M as of Dec 31, 2025, or about $7.72 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition